Dyslipidémies et maladies cardiovasculaires: vers de nouvelles perspectives [Dyslipidemias and cardiovascular diseases: towards a new perspective]

Détails

ID Serval
serval:BIB_8A8D13B321B8
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Dyslipidémies et maladies cardiovasculaires: vers de nouvelles perspectives [Dyslipidemias and cardiovascular diseases: towards a new perspective]
Périodique
Revue Médicale de la Suisse Romande
Auteur(s)
Darioli R., Depairon M., Perdrix J., Mooser V.
ISSN
0035-3655
Statut éditorial
Publié
Date de publication
2002
Volume
122
Numéro
10
Pages
489-493
Langue
français
Résumé
During the last decades, new developments in the detection and therapy of dyslipidemia provided a firm conviction for the efficacy and the safety of lipid-lowering therapies in primary and secondary prevention of cardiovascular diseases. To be cost-effective in primary prevention, the statin-therapy needs to select high risk patients. According to the guidelines, the global assessment of cardiovascular risk is based on traditional risk factors (RF-CV). The emergence of new RF-CV is helpful. However, at every level of risk factor exposure, there is a substantial variation of atherosclerosis. Thus, subclinical disease measurements, representing the end result of risk exposure may be useful for improving cardiovascular risk prediction. Using the high resolution B-mode ultrasound to detect plaques both on femoral and carotid arteries in asymptomatic patients, our results show the advantages and limits of a non invasive method to improve the selection of eligible patients requiring a more aggressive lipid-lowering therapy.
Mots-clé
Antilipemic Agents, Arteriosclerosis, Cardiovascular Diseases, Echocardiography, Humans, Hyperlipidemias, Patient Selection, Risk Factors
Pubmed
Création de la notice
14/02/2008 16:03
Dernière modification de la notice
20/08/2019 15:49
Données d'usage